A new study published in the journal Cellular and Molecular Life Sciences offers a striking answer. A team of researchers led by Yulei Wang, Zuhao Liu, Yameng Wang, Zhiyu Xing and Meisheng Ma of the Department of Histology and Embryology at Tongji Medical College, Huazhong University of Science and Technology in Wuhan, China, reports that the assembly of the NSL complex is driven by liquid-liquid phase separation, a physical process increasingly recognized as a central organizing principle of the cell interior. At the heart of the discovery is KANSL1, the essential scaffolding subunit of the complex, which the researchers show can condense into droplet-like compartments that recruit the other components and enable the intact complex to form. The work, published as an open-access article, reframes the NSL complex not as a machine that snaps together through rigid lock-and-key contacts alone, but as one whose architecture emerges from the soft-matter physics of biomolecular condensates.

To appreciate the significance of the finding, it helps to understand what the NSL complex actually is. The complex comprises at least seven evolutionarily conserved subunits: KANSL1, KANSL2, KANSL3, WDR5, MCRS1, KAT8 and PHF20, along with two associated factors, OGT and HCF1. KAT8, also known as MOF, is the catalytic engine, a histone acetyltransferase that deposits acetyl groups on histone proteins, thereby loosening chromatin and permitting gene expression. KANSL1, by contrast, contributes no catalytic activity of its own, but it is indispensable. It holds the complex together structurally and regulates its function, and previous work had established that without KANSL1 the complex cannot maintain its integrity. What remained elusive was the molecular mechanism underlying this regulatory role, and that is precisely the gap the new study set out to fill.

The researchers’ attention focused on a specific segment of the KANSL1 protein: intrinsically disordered region 4, or IDR4, a stretch of amino acids spanning residues 733 to 857 near the protein’s C-terminal end. Intrinsically disordered regions are segments of proteins that do not fold into a fixed three-dimensional structure. Instead, they remain floppy and dynamic, a property long considered puzzling but now understood to be crucial for many regulatory functions. One of the most consequential of these functions is liquid-liquid phase separation, the process by which disordered, multivalent proteins coalesce, like oil droplets in water, into concentrated liquid compartments that exchange molecules with their surroundings. Membrane-less organelles such as nucleoli and stress granules form this way, and growing evidence implicates phase separation in the organization of chromatin and transcriptional machinery.

Demonstrating that KANSL1 undergoes phase separation required the team to show that the protein displays the characteristic behaviors of a liquid condensate. The study reports that KANSL1 undergoes liquid-liquid phase separation mediated by IDR4, meaning that this specific disordered segment is both necessary and sufficient to drive the condensation process. In the condensed state, KANSL1-rich droplets behave as spatial hubs. Rather than assembling through a sequence of pairwise protein-protein interactions at some random location in the nucleus, the complex appears to build itself inside these droplets, where the local concentration of components is dramatically elevated. This spatial assembly mechanism solves a practical problem for the cell: finding and correctly combining nine different subunits in the vast nuclear volume becomes far more efficient when one partner first creates a dedicated reaction vessel.

The functional consequences of this condensation are substantial. According to the study, IDR4-dependent phase separation promotes the recruitment of KANSL2 and KANSL3, two of the complex’s conserved subunits, enabling the assembly of the intact NSL complex. In other words, the droplets act as gathering points that draw in the remaining parts and allow the full machine to take shape. Critically, the researchers found that this phase separation is not merely a structural curiosity. It is essential for the histone acetyltransferase activity of the NSL complex, meaning that without the condensation event, KAT8 cannot efficiently carry out the chemical modification of histones that the complex exists to perform. The physical state of the scaffold directly controls the enzymatic output of the machine it supports.

That enzymatic output, in turn, feeds directly into gene regulation. The NSL complex binds preferentially to the promoters of housekeeping genes, and its acetylation of histones at those sites is a key determinant of their transcriptional activity. The new study demonstrates that KANSL1 phase separation is required for the transcriptional regulation of the complex’s target genes, closing the causal chain from a disordered protein segment, through condensate formation and complex assembly, to enzymatic activity, and finally to the expression levels of genes that sustain cellular life. It is a vivid illustration of what biophysicists have argued for years: that the physical organization of the nucleus, down to the mesoscale behavior of individual proteins, can be as important to gene control as the DNA sequence itself.

The researchers also connected their findings to cellular behavior, showing that KANSL1 phase separation governs the proliferation and migration of HeLa cells, a widely used laboratory cell line derived from cervical cancer tissue. This observation carries particular weight given the established links between NSL complex subunits and oncogenesis. If the phase-separated state of KANSL1 is required for the complex to function, then perturbing that state, whether by mutation, altered expression, or pharmacological interference, could in principle disrupt the transcriptional program that cancer cells rely upon. While the study does not claim a therapeutic application, it identifies a concrete biophysical mechanism that could be targeted in future work on cancers and developmental disorders involving NSL complex dysfunction.

The clinical resonance of KANSL1 extends beyond cancer. The gene encoding KANSL1 lies within the 17q21.31 region, and haploinsufficiency of KANSL1 is known to underlie a neurodevelopmental disorder characterized by intellectual disability and developmental delay, a condition closely associated with what is often called Koolen-de Vries syndrome. The new findings suggest a possible mechanistic lens through which such mutations might act: changes that compromise the phase-separation behavior of IDR4, or the disordered region’s ability to recruit partner subunits, could cripple complex assembly even when the protein is present. Testing that idea in patient-derived systems would be a natural next step, and the study’s identification of a specific residue range, 733 to 857, gives researchers a precise molecular handle for such experiments.

More broadly, the work adds to a rapidly expanding catalog of cellular processes organized by biomolecular condensates, and it does so in a domain where the stakes are especially high. Epigenetic regulators such as the NSL complex sit at the intersection of development, disease and basic cellular physiology, and understanding how they assemble has been a longstanding challenge. By showing that a scaffolding subunit can self-organize the assembly of an entire chromatin-modifying machine through phase separation, the study broadens the mechanistic understanding of how liquid-liquid phase separation contributes to multi-protein complex formation and epigenetic gene regulation. It also raises new questions that the field will now pursue: How is the condensation of KANSL1 regulated in time and space? Do disease mutations alter the material properties of the condensates? And can the droplets be modulated, safely and specifically, to treat the disorders that arise when this essential assembly line falters? For now, the study stands as a compelling demonstration that some of the cell’s most important molecular machines are built not on rigid frames, but on droplets of liquid protein.

Subject of Research: Liquid-liquid phase separation of KANSL1 in the assembly and function of the NSL chromatin-modifying complex

Article Title: KANSL1 condensates drive spatial assembly of NSL complex

Article References: Wang, Y., Liu, Z., Wang, Y., Xing, Z., & Ma, M. (2026). KANSL1 condensates drive spatial assembly of NSL complex. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-026-06453-1

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06453-1

Keywords: KANSL1, NSL complex, liquid-liquid phase separation, chromatin, epigenetics, histone acetyltransferase, KAT8, intrinsically disordered regions, gene regulation, housekeeping genes, biomolecular condensates, transcription

The opening keynote set an ambitious tone. Wendy Bickmore, director of the MRC Human Genetics Unit at the University of Edinburgh and a pioneer in functional three-dimensional genome organization, delivered the special EMBO Keynote lecture on how the non-coding genome regulates gene activity. She illustrated that distant enhancers do not always need direct physical contact with their target promoters to activate gene expression, but they must be located within roughly 200 to 300 nanometers of a promoter to function effectively. Bickmore showed that cohesin-mediated loop-extrusion is essential for long-range enhancer action, while also challenging the loop-extrusion model as the sole explanation, presenting evidence from her laboratory of ‘leaky’ insulation across topologically associating domain boundaries that causes bystander activation. She also unveiled a novel histone post-translational modification, H3K115 acetylation, which sits within the histone core rather than on the tail and is enriched precisely at the transcription start site in the nucleosome-depleted region, suggesting it marks a fragile nucleosome strongly associated with active transcription.

On the second day, Lei Stanley Qi, associate professor of bioengineering at Stanford University and a pioneer in CRISPR technology, offered a conceptual reframing of how scientists should interpret chromatin maps. TAD boundaries, he argued, are merely snapshots of chromatin interactions, whereas a cell functions as a living, dynamic system. He drew an evocative parallel with Leonardo da Vinci’s Vitruvian Man, which captures optional configurations of the human body, much as epigenetic figures capture the states of many cells across time and space. Qi described an epistasis mapping approach to enhancer functionality, explaining how redundant, independent, or synergistic enhancer interactions can provide compensatory, fine-tuning, or robust regulatory effects respectively, and noted that BRD4-mediated condensation can facilitate such interactions. Notably, his findings independently confirmed Bickmore’s conclusion that enhancers need spatial proximity to promoters to exert their effects.

The final keynote, from Angelo Lombardo, professor of tissue biology and regenerative medicine at Vita-Salute San Raffaele University and co-founder of Chroma Medicine, delivered perhaps the strongest evidence yet that epigenetic editing can work as a durable therapy. His laboratory discovered that stable gene repression requires simultaneous methylation of DNA and repressive histone marks, and that epigenetic regulators such as DNMT3A/3L and KRAB domains, which catalyze DNA and histone methylation, silence retroviral elements in embryonic stem cells. Inspired by this natural system, the group fused DNMT3A/3L and the KRAB domain of ZNF10 to zinc finger domains targeting specific genomic regions, achieving stable gene repression across multiple cell lines. They recently demonstrated long-term repression of PCSK9, a hepatocyte gene involved in cholesterol homeostasis, in mice for nearly one year, reducing LDL receptor presence on hepatocyte membranes. Strikingly, even after partial liver resection, the induced DNA methylation state and repressed expression were retained in the regrown tissue, showing that these modifications are faithfully inherited. Lombardo also highlighted epigenetic silencing of Hepatitis B virus via induced DNA methylation as a viable therapeutic avenue.

Beyond the keynotes, a wave of technical innovation is reshaping how epigenetic enzymes are understood and improved. Albert Jeltsch of the University of Stuttgart uses Deep Enzymology to systematically investigate the preferred flanking DNA sequences of DNA methyltransferases, finding that different DNA substrates influence DNMT1 efficacy so drastically that allele-specific DNA methylation becomes possible. Saulius Klimašauskas and colleagues at Vilnius University developed a click-chemistry technique for bioorthogonal labeling at sites where individual DNMTs catalyze methylation in live cells, enabling high-resolution chemical ‘tracks’ of epigenetic writers throughout the cell cycle. At Rice University, Jacob Goell reduced the cytotoxicity of the histone acetyltransferase P300 while preserving its enzymatic activity through a single point mutation in the P300 core, and found that P300 primes genes for activation and enhances prime editing efficiency independently of its catalytic function.

Epigenetic reader domains, which evolved over millions of years to recognize specific post-translational modifications, are also becoming central tools, particularly where high-quality antibodies are hard to develop. Tuncay Baubec of Utrecht University presented ChromID, a systematic approach in which a biotin ligase fused to a chromatin reader domain biotinylates nearby proteins; after pull-down and mass spectrometry, the epigenetic proteome at a targeted modification is mapped. EpiCypher’s Matthew Meiners described chimeric tandem reader domains and synthetic, fully chemically defined modified nucleosomes for use as spike-ins in CUT&RUN and CUT&Tag assays, allowing researchers to map reader-PTM interactions and histone modification co-occurrences. Anja Köhler of the University of Stuttgart introduced the Bimolecular Anchor Detector, or BiAD, technology, which combines a sgRNA/dCas9 DNA-binding module with reader-domain detector modules fused to complementary split fluorophore parts, reconstituting fluorescence only when both modules bind in proximity, thereby visualizing epigenetic marks at specific genomic loci in living cells. Meanwhile, Marvin Tanenbaum of the Hubrecht Institute presented stopless-ORF circular mRNAs encoding SunTag epitopes, permitting live-cell single-molecule imaging of ribosome kinetics and revealing that ribosome collisions actually facilitate translation through difficult sequences by resolving stalls.

As the toolbox expands, so does the appetite for unbiased, high-throughput screening. Lacramioara Bintu’s laboratory at Stanford developed dCas9-mediated high-throughput recruitment, or HT-recruit, testing more than 5,000 nuclear protein Pfam domains of human and viral origin for their ability to silence or activate gene expression, alongside a library of 114,288 sequences tiling transcription factors and chromatin regulators. Her characterization was memorably vivid: transcriptional activators tend to be ‘greasy acidic noodles with a little salt, pepper and queso,’ rich in acidic and hydrophobic residues interspersed with serine, proline, or glutamine, while repressors come in more flavors, with KRAB domains the best performers across contexts, including a newly identified KRAB from ZNF705F that outperforms the commonly used ZNF10 KRAB. At UC Berkeley, Michael Herschl screened over 50,000 pairs of epigenetic editors, some with catalytic domains up to 6.3 kilobases, using the COMBINE inducible screening platform, identifying editor combinations that impart long-term epigenetic changes and a bidirectional CRISPR perturbation system capable of activating and repressing genes concurrently. A key insight: domains operating in the same or similar pathways show good perturbation synergy, mimicking their natural collaboration. Samuel Reisman of Duke University, in work toward regenerative therapies, screened over 1,600 human transcription factors with CRISPR activation followed by Perturb-seq single-cell RNA sequencing to map the fidelity and subtype-specificity of astrocyte-to-neuron reprogramming.

Computational advances featured prominently as well. Kim Kira Witetzek of Academia Sinica presented ATAC-Mass, which combines isotopic labeling, ion beam imaging at 100-nanometer resolution, and mass cytometry to integrate epigenomics, proteomics, and three-dimensional nuclear imaging at the single-cell level. Jennifer Spangle of Emory University School of Medicine described a chemoenzymatic technique using an L-methionine analogue that converts into a SAM analogue, tagging methylated proteins with a detectable alkyne; the approach resolves mono-, di-, and trimethylation, histidine methylation, and arginine methylation with site specificity, works in vivo and across the blood-brain barrier, and identified 221 proteins with novel methylation sites upon enrichment. Philipp Schnee of the University of Stuttgart showed how 3D molecular dynamics simulations can predict enzyme behavior, enabling the design of a ‘Super-Substrate’ for protein lysine methyltransferases that outcompetes natural substrates with substantially increased specificity. Kimberley Glass of Brigham and Women’s Hospital presented SPIDER, a computational modeling tool that builds gene regulatory networks from DNase-seq, ATAC-seq, or DNA methylation data, prunes false positives using chromatin states, and accurately predicts ChIP-seq transcription factor binding events lacking a corresponding sequence motif, a persistent weakness of older pipelines.

The field’s clinical momentum was matched by growing candor about its risks. Jamie Hackett of EMBL Rome used CRISPR-dCas9 perturbation screens to dissect causal regulatory roles, finding that blocking histone tail acetylation prevents transcriptional activation after H3K4me3 deposition, and that gene permissiveness to epigenetic reprogramming depends on cell type, expressed factors, and DNA sequence. Domitilla del Vecchio of MIT proposed that H3K9me3 causally follows DNA methylation, noting that KRAB alone does not confer long-term memory while DNMT3A does. Bas van Steensel of the Netherlands Cancer Institute used transposon systems to relocate enhancers, promoters, and CTCF sites across a two-megabase window, discovering that enhancers communicate with gene bodies as well as promoters. On safety, Henriette O’Geen of UC Davis showed that hundreds of CpGs retain off-target methylation 24 days after transient editing, particularly at bivalent genes poised for transcription and implicated in oncogenesis, prompting a call for a gold standard for reporting off-target effects; Majid Pahlevan Kakhki of Karolinska Institutet independently reported widespread unintended methylation across nearly all CRISPR-dCas9 tools, including CRISPRoff. In applied settings, Pernette Verschure’s group found transcription burst size predicts gene responsiveness in hormone-sensitive breast cancer, while Gabriella Ficz of Barts Cancer Institute demonstrated ex vivo epigenetic editing of CDKN2B in umbilical cord hematopoietic stem cells, with durable methylation maintained after engraftment in mice and inherited across myeloid and lymphoid lineages. Ivana Parker of the University of Florida, meanwhile, mapped the epigenetic pathways underlying BCG vaccine-induced macrophage activation. Together, the Amsterdam meeting captured a field in confident transition: from conceptual understanding of chromatin’s static architecture to the dynamic, engineered, and increasingly therapeutic manipulation of the epigenome, balanced by a maturing commitment to safety, standardization, and open collaboration between academia and industry.

Subject of Research: Epigenetic editing technologies and their translation from bioengineering innovations toward clinical therapies

Article Title: Bridging bioengineering and epigenetics: from technical innovations to clinical applications

Article References: Jacob, J., van Loosen, Q. C., van den Berg van Saparoea, A. C. H., Sarno, F., & Verschure, P. J. (2024). Bridging bioengineering and epigenetics: from technical innovations to clinical applications. Epigenetics Communications, 4(1), Article 8. https://doi.org/10.1186/s43682-024-00031-x

Image Credits: AI Generated

DOI: 10.1186/s43682-024-00031-x

Keywords: epigenetics, bioengineering, CRISPR, epigenome editing, DNA methylation, chromatin, gene regulation, clinical applications, off-target effects, high-throughput screening, transcription, gene therapy

The technology at the heart of the study is single-nucleus RNA sequencing, a method that captures the RNA content of individual nuclei rather than averaging signals across bulk tissue. Because plant cells are locked inside rigid cell walls, isolating intact single cells is notoriously difficult, which is why many plant genomics teams work with nuclei instead. By profiling nuclei one at a time, researchers can determine which genes are switched on in each cell and, from those expression signatures, assign cells to their types. Applied across an entire organism, the approach produces something akin to a census: a comprehensive tally of the cell types present in each organ, along with the molecular identities that define them.

What makes the new atlas distinctive is its breadth. The team profiled material from ten soybean organs, integrating the resulting datasets into a single unified resource that the authors refer to as Tabula Glycine max, a nod to earlier whole-organism cell atlases in animal systems. Integration is the critical technical step here. Individual sequencing runs are noisy and batch-dependent, so combining data from roots, leaves, stems, flowers, pods and other organs requires computational methods that align cell populations across samples while preserving genuine biological differences. The result is a coordinated map in which equivalent cell types from different organs can be compared directly, revealing both shared identities and organ-specific specializations.

The conceptual payoff of the atlas centers on transcription factors, the proteins that bind DNA and control when other genes are turned on. Transcription factors sit at the top of gene regulatory hierarchies, and in animal biology a long line of work has shown that small sets of co-expressed transcription factors, sometimes called core regulatory circuits, act as the keystones of cell identity. If a cell keeps a particular combination of these master regulators active, it maintains its specialized character; if the combination is disrupted, the cell can lose or transform its identity. Whether the same principle organizes plant tissues has been harder to establish, largely because plant cell atlases matured later than their animal counterparts.

The soybean data provide strong support for that principle in plants. By systematically searching the atlas for transcription factor genes that are co-expressed within specific cell types, the researchers found that distinct sets of these regulatory genes are switched on together in organ- and cell-type-specific patterns. In other words, the regulatory logic of a soybean cell is not just a matter of which transcription factors it possesses in its genome, but of which subsets of them are active in combination, and those combinations differ from one cell type to the next and from one organ to another. The authors highlight this as evidence that co-expressed transcription factors may play a central role in maintaining the functional identity of plant cell types, mirroring the core circuit architecture documented in animals.

There is a practical reason why this matters for agriculture. Soybean is a paleopolyploid, meaning its genome was duplicated in the distant evolutionary past, leaving it with many redundant or partially redundant gene copies. That complexity has long complicated efforts to connect genes to traits, because knocking out a single gene often produces little visible effect. A cell-type-resolved atlas cuts through some of that ambiguity by showing exactly where, and in what cellular context, each transcription factor gene is active. A regulator that is silent in leaves but strongly co-expressed in root hairs, for example, points breeders and biotechnologists toward the developmental processes and agronomic traits, such as nutrient uptake or nodulation, that it is most likely to influence.

The new resource also builds on an earlier chapter of soybean genomics. In 2010, researchers published the sequence of the palaeopolyploid soybean genome, a landmark that supplied the reference needed to map sequencing reads back to genes, and in the same era an organ-level transcriptome atlas of the crop model Glycine max was assembled to guide comparative analyses across plants. Those atlases, powerful as they were, averaged gene activity across all the cells within each organ. The single-nucleus approach resolves what the older resources blurred, exposing the specialization of individual cell populations that had previously been hidden inside tissue-level averages.

The study also situates soybean within a broader scientific movement. Large-scale cell atlases have transformed biomedical research in recent years, exemplified by high-resolution transcriptomic and spatial atlases covering the entire mouse brain, and evolutionary biologists have argued that understanding the origin and diversification of cell types is one of the central questions of biology. Bringing that analytical framework to a crop plant signals a maturing of plant single-cell genomics, and it raises the prospect of comparative atlases that line up cell types across species, from legumes to cereals to model plants such as Arabidopsis, to trace how regulatory programs have been redeployed or rewired over evolutionary time.

For the research community, the immediate value of Tabula Glycine max lies in its utility as a reference. Any soybean gene with unknown function can now be looked up in the atlas to see which cell types express it and which transcription factor modules accompany that expression, generating hypotheses that can then be tested with genetics. For crop improvement, the atlas provides a scaffold for engineering traits with cellular precision: if a desired pathway is to be activated only in a particular cell type, the co-expressed transcription factor sets identified in this study supply candidate switches for driving that activation. And because the co-expression patterns highlight regulators that maintain cell identity, they may also inform efforts to manipulate developmental pathways, from root architecture to seed composition, that depend on specific cells doing specific jobs. As single-cell resources accumulate across crops, the soybean atlas stands as a demonstration that the regulatory grammar of cell identity, first worked out in animals, can now be read in the plants that feed the world.

The briefing format itself is worth a note. Published in Nature Plants research briefings on 10 September 2026, the summary sits alongside the underlying study by Thibivilliers and colleagues, which appeared in the same journal under the title describing the decoding of cell-type-specific co-expressed transcription factors in soybean. Research briefings of this kind are written to distill technical papers for specialists in adjacent fields, and in this case the distillation emphasizes the central claim: that co-expressed transcription factor genes mark organ- and cell-type-specific programs across the plant.

The published figure accompanying the briefing, labeled as the establishment and cell clustering of Tabula Glycine max, points to the analytical workflow behind the resource. Clustering is the step in which single-nucleus profiles are grouped by similarity, allowing nuclei with matching expression signatures to be assigned as putative cell types. It is through such clustering, applied after integration across the ten organs, that the co-expressed transcription factor sets could be detected within each group rather than across whole tissues.

The bibliography of the briefing also sketches the intellectual lineage of the work. It connects the new atlas to the soybean genome sequence reported in 2010, to the earlier organ-level transcriptome atlas of Glycine max, to reviews on the origin and evolution of cell types, and to work framing transcription factor networks as determinants of cell identity, as well as to the recent whole-mouse-brain atlas. Together these citations place the soybean resource at the meeting point of crop genomics, evolutionary cell biology, and large-scale single-cell reference science.

Subject of Research: A soybean transcriptome atlas reveals organ- and cell-type-specific sets of co-expressed transcription factors

Article Title: A soybean transcriptome atlas reveals organ- and cell-type-specific sets of co-expressed transcription factors

Article References: A soybean transcriptome atlas reveals organ- and cell-type-specific sets of co-expressed transcription factors. (2026). Nature Plants. https://doi.org/10.1038/s41477-026-02412-7

Image Credits: AI Generated

DOI: 10.1038/s41477-026-02412-7

Keywords: soybean, transcriptome, atlas, reveals, organ-, cell-type-specific, sets, co-expressed, transcription, factors, scientific research

Transcription factors regulate gene activity by recognizing specific DNA sequences and influencing whether nearby genes are switched on or off. Their binding sites are embedded in chromatin, the complex of DNA and proteins that packages the genome. Because chromatin structure changes as cells develop or respond to signals, researchers need methods that can map both accessible regions and the physical protection provided by bound proteins. Chromatin-accessibility assays such as MNase-seq, DNase-seq and ATAC-seq infer this organization by fragmenting DNA with enzymes, sequencing the resulting pieces and examining where fragment ends occur. A bound transcription factor can shield a short stretch of DNA from cutting, leaving a footprint in the data. Yet the enzymes themselves may cut some DNA sequences more readily than others. Those sequence preferences can produce apparent footprints at sites where no transcription factor is present, complicating efforts to connect genomic patterns with regulatory activity.

V-plot analysis offers a way to visualize these fragment patterns in two dimensions. For each sequenced DNA fragment, researchers plot its length against the distance between its center and a selected transcription-factor motif. When many fragments are displayed together, their arrangement can form a V-like shape. Fragments that retain information about a protected region tend to occupy the area inside the V, while fragments lacking a remnant of the footprint are represented outside it. The shape is therefore not merely a one-dimensional dip in enzyme cutting; it reflects the relationship between fragment size and position relative to the motif. In routine analyses, researchers may identify a V-shape by eye, but the study argues that visual resemblance alone is insufficient. Sequence bias can generate a V-shaped distribution too, meaning that a motif-associated pattern must satisfy additional geometric and quantitative conditions before it is interpreted as evidence of transcription-factor occupancy.

To investigate the distinction, the researchers examined CTCF, a widely studied transcription factor, using low-dosage micrococcal nuclease sequencing in K562 cells. They compared three classes of genomic locations: highly occupied CTCF motifs positioned near an MNase sequence-bias site, weakly occupied CTCF motifs with a nearby bias sequence, and MNase-bias sequences lacking a nearby CTCF motif. V-shapes appeared in all three categories, confirming that the presence of the pattern itself could not establish binding. Their appearances, however, differed. At occupied CTCF motifs, the V-shape contained a visibly broad channel with few or no signals. This gap is consistent with a region protected from digestion by the bound factor. At MNase-bias sequences, the channel was much narrower, suggesting that the pattern could arise from preferential cleavage rather than a protected protein-DNA interface. Fragment signals were also enriched inside the V at occupied motifs, whereas bias-generated patterns showed a more even distribution between the inside and outside regions.

The authors used several complementary observations to test that interpretation. A CTCF chromatin immunoprecipitation dataset showed strong enrichment within the inside-V area at occupied motifs, an independent indication that the pattern coincided with CTCF binding. The same enrichment was not seen at MNase-bias sequences. Analysis of fragment ends revealed another difference: at occupied motifs, the two flanking digestion hotspots were separated by a broad interval, consistent with a protected footprint between them. That separation was absent at bias sequences. Similar graphical distinctions emerged when the researchers analyzed DNase-seq and ATAC-seq data, despite the different enzymes and experimental principles involved. DNase I and the Tn5 transposase used in ATAC-seq also have sequence preferences, so the recurring contrast suggests that the proposed tests may help identify enzyme-generated patterns across multiple accessibility platforms rather than being limited to MNase-based experiments.

The first criterion is the width of the V-channel, the horizontal region around the motif that is depleted of signals. In principle, this width should approximate the minimum footprint size—the portion of DNA stringently protected under the experimental conditions. The second is inside-V enrichment, which compares fragment density in the interior of the V with density outside it. The researchers used the ratio of these areas to quantify how strongly fragments were concentrated within the footprint-associated region. Their experiments with MAZ, another transcription factor, showed that inside-V enrichment tracked the factor’s occupancy level: motifs with greater enrichment also displayed stronger MAZ chromatin immunoprecipitation signals. The channel width, by contrast, remained relatively constant across groups with different occupancy levels. This separation suggests that enrichment can reflect how much a factor is present, while channel width may reflect an intrinsic aspect of its DNA contact or the way the experiment captures protection.

These measurements are not fixed universal values. The study found that different transcription factors produced different channel widths, potentially because their structures contact DNA through distinct interfaces. Even for the same factor, channel width varied between datasets, indicating that enzyme kinetics and other experimental conditions influence the apparent length of a footprint. Inside-V enrichment was comparatively stable for a given factor across the datasets examined, although the authors emphasize that both parameters are needed for robust classification. They developed a statistical pipeline that uses channel width and inside-V enrichment to separate V-shapes at transcription-factor motifs from those at bias sequences in MNase-seq, DNase-seq and ATAC-seq data. The approach also helped distinguish occupied CTCF motifs from shuffled or unoccupied motifs, with inside-V enrichment alone providing useful separation when long candidate bias sequences were present.

The findings do not eliminate the need for independent validation, and they do not imply that every footprint can be interpreted without considering enzyme bias, motif quality or cellular context. Instead, they provide a practical framework for making V-plot evidence more discriminating, particularly when high-quality chromatin immunoprecipitation data are unavailable. The researchers also reproduced key features of occupied CTCF footprints through in silico MNase digestion, supporting the proposed relationship between protected DNA and the observed geometry. The study’s sequencing data are available through the Genome Sequence Archive under accession HRA017804, and its analysis code is available on GitHub. By requiring a sufficiently broad protected channel together with measurable fragment enrichment inside the V, the authors conclude that researchers can reduce false discoveries while retaining a straightforward way to inspect transcription-factor binding across chromatin-accessibility datasets.

A useful implication of the study is that footprint discovery should be treated as a comparative classification problem rather than as a search for an isolated visual pattern. The relevant question is not simply whether a V-shape occurs near a recognition motif, but whether its geometry and fragment distribution resemble the behavior expected from protected DNA more closely than the behavior of a sequence favored by the assay enzyme. This distinction is especially important at genomic positions where a transcription-factor motif lies close to a cleavage-bias sequence, because the two signals can overlap and make a one-dimensional accessibility profile difficult to interpret.

The proposed measurements also separate two biological or technical features that are often conflated. Inside-V enrichment provides information about the concentration of footprint-bearing fragments and, in the MAZ analysis, changed with the apparent level of occupancy. Channel width instead describes the span of the protected interval under the particular digestion or transposition conditions. Thus, a weak footprint should not automatically be interpreted as a smaller protein-DNA interface, and a broad channel should not automatically be interpreted as stronger binding. The two quantities answer different questions and should be evaluated together when assigning confidence to a candidate site.

This framework offers a way to organize controls within an analysis. Motif-centered plots can be compared with plots centered on bias sequences, shuffled motifs or motifs considered unoccupied, while keeping the sequencing assay and processing strategy consistent. Such comparisons help reveal whether a threshold separates biological signal from an assay-specific background. The study’s examples further suggest that classification cutoffs cannot be assumed to transfer unchanged between transcription factors or between MNase-seq, DNase-seq and ATAC-seq experiments. A robust application therefore requires estimating the relevant distributions in the dataset being analyzed, rather than importing a single footprint size or enrichment value from another experiment.

The in silico digestion results provide a mechanistic bridge between the diagrams and the sequencing observations. When cleavage is restricted across a motif-sized interval, the simulated fragments reproduce the broad vacant channel and the concentration of fragments within the inside-V region seen at occupied sites. This supports the interpretation that the geometry can arise from protection of DNA rather than from an arbitrary plotting artifact. At the same time, the study’s comparison with CTCF chromatin immunoprecipitation illustrates why orthogonal evidence remains valuable: V-plot criteria improve the specificity of inference, but they do not replace information about protein occupancy when such information can be obtained.

For researchers applying the method, the practical output is therefore more informative than a binary label alone. A candidate motif can be accompanied by its channel-width measurement, inside-to-outside fragment ratio and comparison with appropriate bias controls. Reporting these features makes it easier to distinguish sites supported by both criteria from sites driven mainly by one unusual signal. It also creates a clearer basis for comparing occupancy patterns across motifs, cell states or assay types, while preserving the simple visual inspection that makes V-plots attractive for genome-wide chromatin analysis.

Subject of Research: Transcription-factor footprint detection using V-plot analysis

Article Title: Two essential criteria for transcription factor footprint discovery using V-plot

Article References: Two essential criteria for transcription factor footprint discovery using V-plot. (n.d.). https://doi.org/10.1038/s44320-026-00242-5

Image Credits: AI Generated

DOI: 10.1038/s44320-026-00242-5

Keywords: transcription factors, V-plot analysis, chromatin accessibility, MNase-seq, DNase-seq, ATAC-seq, enzyme sequence bias, DNA footprints, essential, criteria, transcription, factor